Bermingham Nessan 4
4 · F-star Therapeutics, Inc. · Filed Jun 22, 2022
Insider Transaction Report
Form 4
Bermingham Nessan
Director
Transactions
- Award
Stock Option
2022-06-17+20,000→ 20,000 totalExercise: $3.41Exp: 2032-06-17→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]These options were granted under the Issuer's non-employee director compensation program.
- [F2]Shares under the award shall vest in 12 equal monthly installments over a one-year period through June 16, 2023, subject to the Reporting Person's continued service as a director of the company.